MILLENNIUM MANAGEMENT LLC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,084,836
-77.6%
275,339
-39.5%
0.00%
-50.0%
Q2 2023$4,837,872
+346452.4%
455,115
+171.7%
0.00%
+100.0%
Q1 2023$1,396
-63.9%
167,529
-60.0%
0.00%
-50.0%
Q4 2022$3,869
-100.0%
419,179
-36.1%
0.00%
-60.0%
Q3 2022$8,422,000
-32.9%
655,949
-30.9%
0.01%
-37.5%
Q2 2022$12,545,000
+39.2%
949,658
+121.9%
0.01%
+60.0%
Q1 2022$9,009,000
+150.9%
427,997
+186.0%
0.01%
+150.0%
Q4 2021$3,590,000
+157.3%
149,625
+172.9%
0.00%
+100.0%
Q3 2021$1,395,000
-54.8%
54,825
-31.0%
0.00%
-50.0%
Q1 2021$3,087,000
-49.0%
79,477
-68.7%
0.00%
-75.0%
Q2 2020$6,058,000
+133.1%
254,229
+124.0%
0.01%
+33.3%
Q1 2020$2,599,000
-71.5%
113,493
-64.8%
0.01%
-45.5%
Q4 2019$9,130,000
-39.1%
322,381
-53.8%
0.01%
-54.2%
Q3 2019$14,995,000
-7.0%
697,811
+26.2%
0.02%0.0%
Q2 2019$16,123,000552,7300.02%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 17,161,713$666,561,00074.20%
RTW INVESTMENTS, LP 3,644,248$141,543,0002.21%
Redmile Group, LLC 2,544,062$98,811,0001.39%
Cormorant Asset Management, LP 1,437,807$55,844,0001.24%
ACUTA CAPITAL PARTNERS, LLC 45,000$1,748,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 150,729$5,854,0000.45%
HighVista Strategies LLC 13,692$532,0000.40%
Birchview Capital, LP 15,000$583,0000.35%
Perceptive Advisors 671,978$26,100,0000.33%
GILDER GAGNON HOWE & CO LLC 1,265,950$49,169,0000.26%
View complete list of STOKE THERAPEUTICS INC shareholders